GREG MADDEN is listed as an executive officer and director on 13 SEC Form D filings by 7 issuers between Mar 2016 and Jun 2026. Largest by amount reported sold: SV Life Sciences Fund IV CF, L.P. (Boston, MA — pooled investment fund — 2022; $421.4M reported sold to 44 investors), AcuFocus, Inc. (Irvine, CA — biotechnology — 2018; $74.9M reported sold to 23 investors), Direct Flow Medical, Inc. (Santa Rosa, CA — other health care — 2016; $40.3M reported sold to 36 investors), CardioFocus, Inc. (Marlborough, MA — other technology — 2018–2019; $31.7M reported sold to 32 investors), SPINEOLOGY INC (St. Paul, MN — biotechnology — 2024–2026; $25M reported sold to 80 investors) and 2 more (all listed below).
What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $612.3M sold in total.
The issuers belong to 2 sponsor groups: Sv7 (2 issuers, $91.3M reported sold, 2019–2022) and Sv Life Sciences (10 issuers, $1.56B reported sold, 2010–2026).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 13 public filings for GREG MADDEN and found 8 differences, 1 worth asking the sponsor about: Form D filed 224 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.